Pasithea Therapeutics Corp. · NASDAQ:KTTA

Stonepine Capital Management, LLC reported a 5.80% stake in Pasithea Therapeutics Corp. (Schedule 13G)

Event Jun 17, 2026 · Filed Jun 23, 2026

Stonepine Capital Management, LLC reported a 5.80% stake in Pasithea Therapeutics Corp., 1,952,550 shares, as a passive investor on Jun 17, 2026. Filed Jun 23, 2026 (Schedule 13G).

Stake
5.80%
Shares
1,952,550
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Stonepine Capital Management, LLC5.80%1,952,550
Stonepine Capital, L.P.5.80%1,952,550
Stonepine GP, LLC5.80%1,952,550
Jon M. Plexico5.80%1,952,550

Source

View original at SEC

Related